Gold-graphene nanodots under blue light eliminate 99.7% of MRSA bacteria in lab tests
The treatment simultaneously removes dead tissue and stimulates collagen production
Human trials could begin within 18 months pending FDA approval
Military medics and diabetes clinics are first in line for deployment
The nanodots remain active for 72 hours post-application, providing continuous treatment between dressing changes.